Cleared Traditional

K942784 - NORFOLK OMEGA PORT-LP SUBCUTANEOUSLY IMPLANTED

K942784 is an FDA 510(k) clearance for NORFOLK OMEGA PORT-LP SUBCUTANEOUSLY IM..., manufactured by Norfolk Medical Products, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 322-day FDA review.

K942784 · Norfolk Medical Products, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1995
Decision
322d
Days
Class 2
Risk

K942784 is an FDA 510(k) clearance for the NORFOLK OMEGA PORT-LP SUBCUTANEOUSLY IMPLANTED. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Norfolk Medical Products, Inc. (Skokie, US). The FDA issued a Cleared decision on May 2, 1995 after a review of 322 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Norfolk Medical Products, Inc. devices

FDA 510(k) Submission Details - K942784

510(k) Number K942784 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 1994
Decision Date May 02, 1995
Days to Decision 322 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
193d slower than avg
Panel avg: 129d · This submission: 322d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 233
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K942784.
THEREX LOW PROFILE TITANIUM MODEL 1.0MM I.D./1.8MM O.D.
K952537 · Therex Corp. · Jul 1995
VITAL-PORT PETITE DUAL VASCULAR ACCESS SYSTEM
K951076 · Med Institute, Inc. · Jun 1995
CELSITE(TM) BRACHIAL VENOUS PORT
K945752 · B. Braun of America, Inc. · May 1995
CELSITE(TM) DUAL VENOUS SYSTEM
K945551 · B. Braun of America, Inc. · Apr 1995
A2 DETACHED DUAL PORT SYSTEM
K950212 · Therex Corp. · Apr 1995
1.0MM 1.8MMO.D. POLYURETHANE DETACHED MODEL
K950131 · Therex Corp. · Mar 1995